Martin Blogg

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR

A M Vignola, Marc Humbert, Jean Bousquet et al. · Allergy · 2004 · 403 citations

Predicting and evaluating response to omalizumab in patients with severe allergic asthma

Jean Bousquet, Klaus F. Rabe, Marc Humbert et al. · Respiratory Medicine · 2007 · 302 citations · Full text

Asthma, Translational Medicine, Allergy +5

Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate‐to‐severe) allergic asthma

Jon G. Ayres, Bernard Higgins, Edwin R. Chilvers et al. · Allergy · 2004 · 276 citations

Omalizumab and the risk of malignancy: Results from a pooled analysis

William W. Busse, Roland Buhl, Carlos Fernández Vidaurre et al. · Journal of Allergy and Clinical Immunology · 2012 · 168 citations

Epidemiology, Cancer Risk, Medicine +11